|
1
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei WI and Kwong DL: Current management
strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol.
3:1–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Clin Chem. 55:623–631. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. MicroRNA Cancer Regulation Springer.
1–20. 2013.http://dx.doi.org/10.1007/978-94-007-5590-1_1
View Article : Google Scholar
|
|
9
|
Incoronato M, Garofalo M, Urso L, Romano
G, Quintavalle C, Zanca C, Iaboni M, Nuovo G, Croce CM and
Condorelli G: miR-212 increases tumor necrosis factor-related
apoptosis- inducing ligand sensitivity in non-small cell lung
cancer by targeting the antiapoptotic protein PED. Cancer Res.
70:3638–3646. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ucar A, Vafaizadeh V, Jarry H, Fiedler J,
Klemmt PA, Thum T, Groner B and Chowdhury K: miR-212 and miR-132
are required for epithelial stromal interactions necessary for
mouse mammary gland development. Nat Genet. 42:1101–1108. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiping Z, Ming F, Lixiang W, Xiuming L,
Yuqun S, Han Y, Zhifang L, Yundong S, Shili L, Chunyan C, et al:
MicroRNA-212 inhibits proliferation of gastric cancer by directly
repressing retinoblastoma binding protein 2. J Cell Biochem.
114:2666–2672. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q,
Yang W, Yao Y, Liu Q and Tu K: MicroRNA-212 suppresses tumor growth
of human hepatocellular carcinoma by targeting FOXA1. Oncotarget.
6:13216–13228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meng X, Wu J, Pan C, Wang H, Ying X, Zhou
Y, Yu H, Zuo Y, Pan Z, Liu RY, et al: Genetic and epigenetic
down-regulation of microRNA-212 promotes colorectal tumor
metastasis via dysregulation of MnSOD. Gastroenterology.
145:426–436.e1-6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Walter BA, Valera VA, Pinto PA and Merino
MJ: Comprehensive microRNA profiling of prostate cancer. J Cancer.
4:350–357. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H,
Wang W, Huang X, Yuan Z and Ai K: miR-212 promotes pancreatic
cancer cell growth and invasion by targeting the hedgehog signaling
pathway receptor patched-1. J Exp Clin Cancer Res. 33:542014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao
X, Feng J, Zhang Y, Gao H, Liu DX, et al: SOX4 induces
epithelial-mesenchymal transition and contributes to breast cancer
progression. Cancer Res. 72:4597–4608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koumangoye RB, Andl T, Taubenslag KJ,
Zilberman ST, Taylor CJ, Loomans HA and Andl CD: SOX4 interacts
with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal
cancer cells. Mol Cancer. 14:242015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun R, Jiang B, Qi H, Zhang X, Yang J,
Duan J, Li Y and Li G: SOX4 contributes to the progression of
cervical cancer and the resistance to the chemotherapeutic drug
through ABCG2. Cell Death Dis. 6:e19902015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi S, Cao X, Gu M, You B, Shan Y and You
Y: Upregulated expression of SOX4 is associated with tumor growth
and metastasis in nasopharyngeal carcinoma. Dis Markers.
2015:6581412015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang J, Ko JY and Hong RL: Recent
advances in the treatment of nasopharyngeal carcinoma. J Formos Med
Assoc. 103:496–510. 2004.PubMed/NCBI
|
|
21
|
Hampton T: MicroRNA and metastasis. JAMA.
298:1998. 2007. View Article : Google Scholar
|
|
22
|
Wong AM, Kong KL, Tsang JW, Kwong DL and
Guan XY: Profiling of Epstein-Barr virus-encoded microRNAs in
nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Cancer. 118:698–710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aaboe M, Birkenkamp-Demtroder K, Wiuf C,
Sørensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjøt L and
Ørntoft T: SOX4 expression in bladder carcinoma: Clinical aspects
and in vitro functional characterization. Cancer Res. 66:3434–3442.
2006. View Article : Google Scholar : PubMed/NCBI
|
